Assignee
D2G ONCOLOGY INC
US·0 granted patents·2 pending applications·0 citations·filing 2022–2023
Top patents by PatentIndex Score
2 records- 0149US2023304102A1Biomarkers for predicting responsiveness to shp2 inhibitor therapyD2G ONCOLOGY INC·Filed 2023·Application pending·0 cites
- 0248US2023383360A1Biomarkers for predicting responsiveness to mek inhibitor monotherapy and combination therapyD2G ONCOLOGY INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when D2G ONCOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →